Skip to main content
. 2021 Jun 15;17:1927–1936. doi: 10.2147/NDT.S314440

Figure 1.

Figure 1

Responses of patients and their referring psychiatrists regarding the difficulty of reducing the dose of BDZs.

Notes: The box shaded with vertical lines shows a type A discrepancy (patients perceive a reduction in the dose of BDZs to be more difficult than their referring psychiatrists do). The box shaded with horizontal lines shows a type B discrepancy (patients perceive a reduction in the dose of BDZs to be less difficult than their referring psychiatrists do).